Searched for
CADILA LABORATORIES
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Risk-reward ratio is favourable in select pharma companies: CLSACLSA sees a favourable risk-to-reward ratio in shares of Dr Reddy's Laboratories, Cadila Healthcare and Torrent Pharma. The brokerage has u...
- Stock market update: Nifty Pharma index falls 0.69% in a weak marketThe Nifty Pharma index was trading 0.69 per cent down at 13231.95.
- Government lab releases first batch of Zydus Cadila's covid vaccine ZyCoV-DNeedle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...
- India's Shilpa Medicare to make Cadila's COVID-19 vaccineThe country's health authorities had given emergency approval in August for Cadila's vaccine, the world's first COVID-19 DNA shot, in adult...
- Dr Reddy's, Zydus Pharma recall products in US marketAs per the report by the USFDA, Zydus Pharmaceuticals (USA) Inc, is recalling 2,880 bottles of Carvedilol tablets, USP 25 mg in the US due ...
- Stock market update: Nifty Pharma index climbs over 2%; Cadila leaps over 6%The index was trading 2.13 per cent up at 13538.65.
- Stock market update: Pharma stocks gain; Cadila Healthcare rises over 1%The Nifty Pharma index was trading 0.32 per cent up at 11618.2.
- Stock market update: Cadila, Sun Pharma, Lupin boost Nifty Pharma packThe Nifty Pharma index was trading 1.03 per cent up at 8,202 around 12:30 pm.
- Stock market update: Sun Pharma drives Nifty Pharma index upThe Nifty Pharma index was trading 2.61 per cent up at 8,514 around 01:30 pm.
- Pharma stocks soar despite US lawsuitAmong other listed stocks out of the five, Cadila Healthcare gained 2.87 per cent at Rs 512 at around the same time.
- Market now: Pharma stocks surge up to 9% ahead of RBI's monetary policy outcomeRBI held repo rate at a six-year low of 6.25 per cent on April 6, 2017 and reverse repo rate by 0.25 per cent to 6 per cent.
- Zydus Cadila to launch seasonal flu vaccine in IndiaDisease prevention is key to public health in both developing and the developed world and vaccines have the potential to improve the qualit...
- US FDA points to loose quality controls, data deletions at Zydus Cadila’s two facilitiesThe letter of December 23 stated examples of data deletions at the Moraiya and the unit’s failure to “adequately control the use of compute...
- Cadila Pharma Chairman Indravadan Modi dies at 87Founder of Ahmedabad-based Cadila Pharmaceuticals, Indravadan Modi, better known as the octogenarian horse-riding chairman, passed away at ...
- Zydus Cadila concludes deal to re-launch Urokinase drugZydus Cadila concludes agreement with Canadian biotech company Microbix Biosystems to re-launch KINLYTIC, a life saving drug in North Ameri...
- Zydus Cadila buys Spain's Laboratories CombixDrug maker Zydus Cadila on Friday announced its foray into Spain, the fifth largest pharmaceutical market in the world.
- Abbott files patent suit against Zydus Cadila in US courtUS-based Abbott Laboratories seeks to stop the Indian company, Zydus Cadila, from selling generic version of its drug, Depakote, in the US.
- Ranbaxy, Cadila gets USFDA nod for CarvedilolRanbaxy Laboratories and Cadila Healthcare have received approval from the USFDA for Carvedilol tablets in the strengths - 3.125 mg, 6.25 m...
Load More- Stock market update: Nifty Pharma index falls 0.69% in a weak market
